Skip to main content
Virbac logo

Virbac — Investor Relations & Filings

Ticker · FR000 ISIN · FR0000031577 LEI · 969500QQ1X5XHG649644 PA Manufacturing
Open in API
Filings indexed 975 across all filing types
Latest filing 2016-01-14 Earnings Release
Country FR France
Listing PA FR000

About Virbac

https://corporate.virbac.com/home.html

Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Founded in 1968 by a veterinarian, the company provides veterinarians, farmers, and pet owners with a comprehensive range of products and services. Its portfolio of innovative solutions covers the majority of animal species and diseases, with a focus on both companion and farm animals. Key product areas include vaccines, dermatology, parasite control, dental care, nutrition, and diagnostics. Through its international R&D network, Virbac develops solutions to prevent, diagnose, and treat animal pathologies, contributing to animal welfare and supporting sustainable farming.

Recent filings

Filing Released Lang Actions
Virbac : annual sales growth of 10.2%,
Earnings Release Classification · 97% confidence The document provides a detailed summary of Virbac's consolidated revenue for the fourth quarter and the full year 2015, including comparisons to previous periods and breakdowns by geography and species segment. It explicitly states 'Total 2015 annual sales reached 852.2 M€' and includes a table with 'Net annual revenue'. This content structure—a comprehensive review of annual financial performance—is characteristic of an Annual Report (10-K) or a preliminary release thereof. However, since the text is a 'Public release' dated January 14th, 2016, and focuses on summarizing the full year's results rather than being the full, audited 10-K filing itself, it most closely aligns with an Earnings Release (ER) which announces periodical financial results. Given the depth of the annual figures presented, it is more substantial than a typical quarterly ER, but it is not the full 10-K. Since it covers the full year's performance and is a public release, it functions as the primary announcement of the annual results, fitting the 'Earnings Release' category best, even though it covers the full year instead of just a quarter. It is not a Call Transcript (CT) or an Investor Presentation (IP) as it lacks Q&A or presentation slides structure. It is a summary announcement of the annual results. FY 2015
2016-01-14 English
Virbac : chiffre d’affaires annuel en croissance de 10,2% tirée par le
Earnings Release Classification · 98% confidence The document is titled with annual revenue figures ("chiffre d'affaires annuel") and provides detailed financial performance metrics for the full year 2015 compared to 2014, including quarterly breakdowns. It presents key financial highlights and outlooks. Although it is a press release format ("Communiqué diffusé le 14 janvier 2016") and not the formal 10-K filing itself, its primary function is the initial announcement of the full-year financial results. This aligns best with the 'Earnings Release' (ER) category, which covers the initial announcement of periodical financial results (in this case, annual results). It is too detailed for a simple RPA, and it is not the comprehensive annual report (10-K) or an interim report (IR). FY 2015
2016-01-14 French
Virbac : bilan semestriel contrat de liquidité au 31 décembre 2015
Regulatory Filings Classification · 99% confidence The document is titled "BILAN SEMESTRIEL DES MOYENS ALLOUES AU CONTRAT DE LIQUIDITE" (Semi-annual balance sheet of means allocated to the liquidity contract) and reports the status of a liquidity contract (market making agreement) as of December 31, 2015, comparing it to the previous balance on June 30, 2015. This type of regular reporting on liquidity agreements, often related to share trading support, is a specific financial disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a standard Interim Report (IR). Given the specific nature of reporting on liquidity providers and share/cash balances under such a contract, it most closely aligns with a specialized financial disclosure. Since there is no direct category for 'Liquidity Contract Balance Sheet', and it deals with the mechanics of share availability and cash reserves related to market operations, it fits best under the general 'Regulatory Filings' (RNS) as a specific, non-standard disclosure, or potentially under 'Capital/Financing Update' (CAP) if interpreted broadly as market support, but RNS is safer for specific, non-core financial statements. However, upon reviewing the definitions, none perfectly match a 'Liquidity Contract Balance Sheet'. It is a periodic financial update related to market stability/share availability. Given its periodic nature (semi-annual) and financial content, it is a specific regulatory disclosure. I will classify it as RNS as the best fit for a specific, non-core periodic financial report not covered by IR or 10-K.
2016-01-11 French
Déclaration actions et droits de vote 31 Décembre 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document title is "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights). It explicitly provides the total number of shares and the total gross and net voting rights as of a specific date (December 31, 2015), referencing Article 223-16 of the AMF General Regulation. This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official announcements related to voting rights and capital structure related to shareholder rights.
2016-01-06 French
Déclaration d'actions et de droits de vote Novembre 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document title is "DECLARATION D'ACTIONS ET DE DROITS DE VOTE" (Declaration of Shares and Voting Rights). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and the total gross and net voting rights as of a specific date (November 30, 2015). This content directly corresponds to the definition of Declaration of Voting Results & Voting Rights Announcements.
2015-12-01 French
Declaration of the nb of shares and voting rights as of Nov 15
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled 'DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS' and explicitly references Article 223-16 of the French Financial Market Authority (Autorité des Marchés Financiers). It provides a table detailing the 'Total number of voting rights' and 'Total number of shares' as of a specific date (November 30, 2015). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not an AGM presentation, a full annual report, or a management change announcement.
2015-12-01 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.